PhRMA’s star power
Executive Summary
Actor Michael J. Fox is scheduled to deliver the closing keynote address during the Pharmaceutical Research & Manufacturers of America annual meeting April 3 in Palm Beach, Fla. Fox recently returned to acting after seeing improvement in his symptoms of Parkinson's disease. Fox credits his improvement to a new medication he recently began taking; in media interviews, Fox has declined to name the product...
You may also be interested in...
Scotland's MGB Plots Phase III For Promising Antibacterial
With a late-stage compound on its hands, MGB is currently in discussions with several biotech and pharma companies and also with venture capitalists to continue late-stage development of a novel antibiotic which could transform treatment of Clostridium difficile.
AstraZeneca Vaccine May Only Gain EU Approval In Under 70s
AZ and the EU are at loggerheads over supplies of the COVID-19 vaccine. On top of that, its marketing authorization will present dilemmas.
Moment Of Truth In EU For Amarin’s ‘Multi-Billion-Dollar Opportunity’ Drug
The European Medicines Agency is expected to decide soon whether Amarin’s fish oil pill, Vascepa, should win pan-EU marketing approval for reducing cardiovascular risk.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: